Sruthi Vijaya Retnakumar

Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases.

E. Ogier-Denis, A. Bretin, Ramasatyaveni Geesala, 2022, Journal of autoimmunity.

Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases.

S. Muller, Sruthi Vijaya Retnakumar, 2019, Trends in molecular medicine.

The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases

J. Bayry, Sruthi Vijaya Retnakumar, C. Chauvin, 2023, Pharmacology & Therapeutics.

Gasdermin D as a cellular switch to orientate immune responses via IL-33 or IL-1β

J. Bayry, Sruthi Vijaya Retnakumar, C. Chauvin, 2022, Cellular & Molecular Immunology.

Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines.

J. Bayry, Sruthi Vijaya Retnakumar, C. Chauvin, 2023, Cell reports. Medicine.

THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”

J. Bayry, Haitao Hu, Sruthi Vijaya Retnakumar, 2023, Vaccines.

Lipophilic derivatives of EGCG as potent α-amylase and α-glucosidase inhibitors ameliorating oxidative stress and inflammation.

Sruthi Vijaya Retnakumar, Sushabhan Sadhukhan, Revathy Sahadevan, 2024, Bioorganic chemistry.